Novel in silico designed inhibitor for BTK enzyme and B-cell lymphoma treatment bynatural fragments

Bruton’s tyrosine kinase (BTK) has been discovered by its critical role in B cell receptor signalingpathway, and for inhibition of malignant B cell growth as well. In this work, we have successfully designed a newinhibitor for BTK enzyme, using natural fragments by in silico studies.

کلیدواژه ها:

anti-cancer drug ، computational drug design ، BTK